Global Lipofection Reagents Market, By Method (Electroporation, Adenoviral Vectors), Product (Reagents, Equipment), Transfection Method (Physical method, Microinjection, Magnetic Beads, Laserfection, Electroporation, Chemical method, Calcium Phosphate Transfection, DEAE-dextran, Dendrimers, Lipofection, Biological method, Viral Transfection), Application (Biomedical Research, Protein Production, Therapeutic Delivery), End User (Academics and Research Institutes, Pharmaceutical and Biotechnology Companies) – Industry Trends and Forecast to 2030.
Lipofection Reagents Market Analysis and Size
As the cancer cases increase and growing demand for synthetic gene will surge the growth of transfection reagent market. Transfection technique are widely used in clinical trials to develop different novel gene therapies based on the delivery of nucleic acids, there will be huge demand for transfection reagents because they are widely used for conducting genetic variation testing procedures. Current advancements relating to developing novel techniques for stable and transient transfection with minimal off-target effects have concerned numerous market players to invest in developing novel products.
Data Bridge Market Research analyses that the lipofection reagents market which was USD 1104.6 million in 2022, would rocket up to USD 2075.02 million by 2030, and is expected to undergo a CAGR of 8.2% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Lipofection Reagents Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Method (Electroporation, Adenoviral Vectors), Product (Reagents, Equipment), Transfection Method (Physical method, Microinjection, Magnetic Beads, Laserfection, Electroporation, Chemical method, Calcium Phosphate Transfection, DEAE-dextran, Dendrimers, Lipofection, Biological method, Viral Transfection), Application (Biomedical Research, Protein Production, Therapeutic Delivery), End User (Academics and Research Institutes, Pharmaceutical and Biotechnology Companies)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Thermo Fisher Scientific (U.S.), Promega Corporation, Hologic, Inc. (U.S.), Luminex (U.S.), BD (U.S.), QIAGEN (Germany), Agilent Technologies Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), MaxCyte, Inc (U.S.), Lonza. (Switzerland), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), Polyplus Transfection (France), Mirus Bio LLC. (U.S.), OriGene Technologies, Inc (U.S.), Altogen Biosystems (U.S.), General Electric (U.S.), Genlantis, Inc. (U.S.), Seegene Inc. (South Korea), Illumina, Inc (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Takara Bio Inc. (Japan), PromoCell GmbH (Germany), Bristol Myers Squibb Company (U.S.), Abbott (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Lipofection reagent is a good alternative for the transfection of plasmid DNA into eukaryotic cells with a simplified protocol. For optimal results in a broader range of plasmid DNA transfection conditions, we suggest this reagent, because of its standard balance of potency and low-cytotoxicity. These nucleic acids can be delivered with the support of transfection reagents and nucleic acid, forming positively charged transfection complex and enabling cellular uptake. Transfection technique are widely used in huge development of gene therapies along with cancer research.
Lipofection Reagents Market Dynamics
Drivers
- Increasing Technological Advancements
Current advancements leading to the development of novel techniques for stable and transient transfection with minimal off-target effects have concerned several market players to invest in the development of different novel products. For instance, in August 2017, the Ohio State University Wexner Medical Center and the Ohio State College of Engineering launched a TNT technology capable of healing tissues and rejuvenating aging cells. Several scientific reserchers at Ohio State University used TNT to treat car crash victims or injured soldiers. The addition of nanotechnology along with transfection is one of the primary factors boosting the market for transfection reagents and equipment.
- Rising Demand of Electroporation
Extensive portfolios for a wide range of electroporation solutions that is offered by established and developing players are increasing segment growth. Recent developments in lipofection to improve the efficiency of in vivo transfection may boost the demand for liposome-based transfection in the upcoming years.
Opportunities
- Increasing R&D Activities by Several Market Players
An increasing number of cancer research projects which are targeted at cancer management are anticipated to boost the market for transfection reagents and equipment during the forecast period. R&D for cancer management witnesses the heavy incorporation of different transfection methods for the development of gene-based therapy and stem cell therapy. For instance, Nucleofector technology which Lonza and FuGENE HD Transfection provide by Promega Corporation helps in the successful transfection of cancer cell lines with utmost efficiency. Likewise, nano-electro-injection was launched by several researchers at the National University of Singapore in October 2019 to confirm the effective delivery of DNA.
Restraints/Challenges
- Lack of Skilled Molecular Techniques
In some very low-income countries, lack of availability of skilful molecular technicians can lead to low usage of multiple transfection reagents. Moreover, cytotoxic effect related with transfection technique and multiple risk factors during insertion of the reagents will help in slowing down the transfection reagents market.
This lipofection reagents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lipofection reagents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Lipofection Reagents Market
With the COVID-19 pandemic, several governing agencies of several countries are primarily focusing on increasing the vaccination drive. Though, the protection and immunity of these vaccines are short-lived because of the emergence of new variants. Thus, there is an increase in the need of transfection reagents and equipment to widely develop multiple innovative strategies or alternatively redevelop the existing treatments to fight against virus infection.
Lipofection Reagents Market Scope
The lipofection reagents market is segmented on the basis of method, product, transfection method, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Method
- Electroporation
- Adenoviral Vectors
Product
- Reagents
- Plasmid transfection reagents
- Protein transfection reagents
- RNA transfection reagents
- Equipment
Transfection Method
- Physical method
- Microinjection
- Magnetic Beads
- Laserfection
- Electroporation
- Chemical method
- Calcium Phosphate Transfection
- DEAE-dextran, Dendrimers
- Lipofection
- Biological method
- Viral Transfection
Application
- Biomedical Research
- Protein Production
- Therapeutic Delivery
End-User
- Academics and Research Institutes
- Pharmaceutical and Biotechnology Companies
Lipofection Reagents Market Regional Analysis/Insights
The lipofection reagents market is analyzed and market size insights and trends are provided by method, product, transfection method, application and end-user as referenced above.
The countries covered in the lipofection reagents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the lipofection reagents market because of the increasing levels of investment on R&D activities along with incidence of well-established manufacturers in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of the growing healthcare expenditure with huge number of patient population.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The lipofection reagents market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for trauma devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the trauma devices market. The data is available for historic period 2011-2021.
Competitive Landscape and Global Lipofection Reagents Market Share Analysis
The lipofection reagents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to lipofection reagents market.
Some of the major players operating in the lipofection reagents market are:
- Thermo Fisher Scientific (U.S.)
- Hologic, Inc. (U.S.)
- Luminex (U.S.)
- BD (U.S)
- QIAGEN (Germany)
- Agilent Technologies Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- MaxCyte, Inc (U.S.)
- Lonza. (Switzerland)
- Merck & Co., Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Polyplus Transfection (France)
- Mirus Bio LLC.(U.S.)
- OriGene Technologies, Inc (U.S.)
- Altogen Biosystems (U.S.)
- General Electric (U.S.)
- Genlantis, Inc. (U.S.)
- Seegene Inc. (South Korea)
- Illumina, Inc (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Takara Bio Inc. (Japan)
- PromoCell GmbH (Germany)
- Bristol Myers Squibb Company (U.S.)
- Abbott (U.S.)
SKU-